for its HFX iQ SCS system. "Medtronic SCS device restores function in SMA trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

SCS will contribute the most significant share to that total, around $4.6bn by 2034. Boston Scientific has 55% of the current market share, followed by Medtronic and then Abbott, as per analysis ...